Home/U.S. Code/Title 21
FEDERAL · U.S. CODE

Title 21 — Food and Drugs

663 sections across 51 chapters. View on OLRC ↗

#1 Ranked Citator APIVerify citations & detect hallucinations across 29M+ references to primary authority.Learn more·API docs
Chapter SUBCHAPTER II—MISCELLANEOUS PROVISIONS
§ 16Introduction into, or sale in, State or Territory or District of Columbia of dairy or food products falsely labeled or branded
§ 17Penalty for sale or introduction of falsely labeled dairy or food products; venue
§ 18Suspension of importation of adulterated articles
§ 20Apples in interstate commerce; standard grades
§ 21Branding grades on barrels of apples
§ 22Barrels misbranded
§ 23Penalties
§ 25Oleomargarine, butterine, or imitation butter or cheese transported into a State subject to its police powers
Chapter 3FILLED MILK
§ 61Definitions
§ 62Manufacture, shipment, or delivery for shipment in interstate or foreign commerce prohibited
§ 63Penalties; acts of agents deemed acts of principals
§ 64Regulations for enforcement
Chapter SUBCHAPTER II—IMPORTATION OF CATTLE AND QUARANTINE
§ 101Suspension of importation of all animals
Chapter SUBCHAPTER III—PREVENTION OF INTRODUCTION AND SPREAD OF CONTAGION
§ 113aEstablishment of research laboratories for foot-and-mouth disease and other animal diseases; research contracts; employment of technicians and scientists; appropriations
§ 114iPseudorabies eradication
§ 136Additional inspection services
§ 136aCollection of fees for inspection services
Chapter SUBCHAPTER IV—IMPORTATION OF MILK AND CREAM
§ 141Prohibition of importation without permit
§ 142Milk or cream when unfit for importation
§ 143Inspection; certified statement in lieu thereof; waiver of requirements of section 142; regulations; suspension and revocation of permits
§ 144Unlawful receiving of imported milk or cream
§ 145Penalties
§ 146Authorization of appropriations
§ 147Repeal of inconsistent laws
§ 148Powers of State with respect to milk or cream lawfully imported
§ 149Definitions
Chapter 5VIRUSES, SERUMS, TOXINS, ANTITOXINS, AND ANALOGOUS PRODUCTS
§ 151Preparation and sale of worthless or harmful products for domestic animals prohibited; preparation to be in compliance with rules at licensed establishments
§ 152Importation regulated and prohibited
§ 153Inspection of imports; denial of entry and destruction
§ 154Regulations for preparation and sale; licenses
§ 154aSpecial licenses for special circumstances; expedited procedure; conditions; exemptions; criteria
§ 155Permits for importation
§ 156Licenses conditioned on permitting inspection; suspension of licenses
§ 157Inspection
§ 158Offenses; punishment
§ 159Enforcement; penalties applicable; Congressional findings
Chapter 7PRACTICE OF PHARMACY AND SALE OF POISONS IN CONSULAR DISTRICTS IN CHINA
§ 201Doing business without a license unlawful; employment of Chinese subjects
§ 202Certain classes of persons and corporations excepted; insecticides
§ 203Application for license; requirements; qualifications for license
§ 204Issuance of license
§ 205Display of license in pharmacy
§ 206Revocation of license
§ 207Restrictions on sales; written orders or prescriptions
§ 208Certain preparations and sales excepted
§ 209Poisons; book entry of sale; labels
§ 210Pharmacist; unauthorized use of title
§ 211Preservation of originals of prescriptions compounded and copies thereof; inspection of prescriptions by consular officers; marking containers of drugs
§ 212Offenses; punishment; duty to enforce provisions
§ 213Fraudulent representations to evade or defeat restrictions
§ 214Previous laws unaffected
§ 215"Consul" defined
Chapter SUBCHAPTER I—SHORT TITLE
§ 301Short title
Chapter SUBCHAPTER II—DEFINITIONS
§ 321Definitions; generally
§ 321a"Butter" defined
§ 321b"Package" defined
§ 321cNonfat dry milk; "milk" defined
§ 321dMarket names for catfish and ginseng
Chapter SUBCHAPTER III—PROHIBITED ACTS AND PENALTIES
§ 331Prohibited acts
§ 332Injunction proceedings
§ 333Penalties
§ 334Seizure
§ 335Hearing before report of criminal violation
§ 335aDebarment, temporary denial of approval, and suspension
§ 335bCivil penalties
§ 335cAuthority to withdraw approval of abbreviated drug applications
§ 336Report of minor violations
§ 337Proceedings in name of United States; provision as to subpoenas
§ 337aExtraterritorial jurisdiction
Chapter SUBCHAPTER IV—FOOD
§ 341Definitions and standards for food
§ 342Adulterated food
§ 343Misbranded food
§ 344Emergency permit control
§ 345Regulations making exemptions
§ 346Tolerances for poisonous or deleterious substances in food; regulations
§ 346aTolerances and exemptions for pesticide chemical residues
§ 346bAuthorization of appropriations
§ 347Intrastate sales of colored oleomargarine
§ 347aCongressional declaration of policy regarding oleomargarine sales
§ 347bContravention of State laws
§ 348Food additives
§ 349Bottled drinking water standards; publication in Federal Register
§ 350Vitamins and minerals
§ 350aInfant formulas
§ 350bNew dietary ingredients
§ 350cMaintenance and inspection of records
§ 350dRegistration of food facilities
§ 350eSanitary transportation practices
§ 350fReportable food registry
§ 350gHazard analysis and risk-based preventive controls
§ 350hStandards for produce safety
§ 350iProtection against intentional adulteration
§ 350jTargeting of inspection resources for domestic facilities, foreign facilities, and ports of entry; annual report
§ 350kLaboratory accreditation for analyses of foods
§ 350lMandatory recall authority
§ 350mRequirements for critical food
§ 343–1National uniform nutrition labeling
§ 343–2Dietary supplement labeling exemptions
§ 343–3Disclosure
§ 350a–1Protecting infants and improving formula supply
§ 350l–1Annual report to Congress
Chapter SUBCHAPTER V—DRUGS AND DEVICES
§ 351Adulterated drugs and devices
§ 352Misbranded drugs and devices
§ 353Exemptions and consideration for certain drugs, devices, and biological products
§ 353aPharmacy compounding
§ 353bOutsourcing facilities
§ 353cPrereview of television advertisements
§ 353dProcess to update labeling for certain generic drugs
§ 354Veterinary feed directive drugs
§ 355New drugs
§ 355aPediatric studies of drugs
§ 355bAdverse-event reporting
§ 355cResearch into pediatric uses for drugs and biological products
§ 355dInternal committee for review of pediatric plans, assessments, deferrals, deferral extensions, and waivers
§ 355ePharmaceutical security
§ 355fExtension of exclusivity period for new qualified infectious disease products
§ 355gUtilizing real world evidence
§ 355hRegulation of certain nonprescription drugs that are marketed without an approved drug application
§ 356Expedited approval of drugs for serious or life-threatening diseases or conditions
§ 356aManufacturing changes
§ 356bReports of postmarketing studies
§ 356cDiscontinuance or interruption in the production of life-saving drugs
§ 356dCoordination; task force and strategic plan
§ 356eDrug shortage list
§ 356fHospital repackaging of drugs in shortage
§ 356gStandards for regenerative medicine and regenerative advanced therapies
§ 356hCompetitive generic therapies
§ 356iPrompt reports of marketing status
§ 356jDiscontinuance or interruption in the production of medical devices
§ 356kPlatform technologies
§ 356lAdvanced manufacturing technologies designation program
§ 357Qualification of drug development tools
§ 358Authority to designate official names
§ 359Nonapplicability of subchapter to cosmetics
§ 360Registration of producers of drugs or devices
§ 360aClinical trial guidance for antibiotic drugs
§ 360bNew animal drugs
§ 360cClassification of devices intended for human use
§ 360dPerformance standards
§ 360ePremarket approval
§ 360fBanned devices
§ 360gJudicial review
§ 360hNotification and other remedies
§ 360iRecords and reports on devices
§ 360jGeneral provisions respecting control of devices intended for human use
§ 360kState and local requirements respecting devices
§ 360lPostmarket surveillance
§ 360mAccredited persons
§ 360nPriority review to encourage treatments for tropical diseases
§ §360aa. Recommendations for investigatio§360aa. Recommendations for investigations of drugs for rare diseases or conditions
§ §360bb. Designation of drugs for rare di§360bb. Designation of drugs for rare diseases or conditions
§ §360bbb. Expanded access to unapproved t§360bbb. Expanded access to unapproved therapies and diagnostics
§ §360cc. Protection for drugs for rare di§360cc. Protection for drugs for rare diseases or conditions
§ §360ccc. Conditional approval of new ani§360ccc. Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
§ §360dd. Open protocols for investigation§360dd. Open protocols for investigations of drugs for rare diseases or conditions
§ §360ddd. Definitions§360ddd. Definitions
§ §360ee. Grants and contracts for develop§360ee. Grants and contracts for development of drugs for rare diseases and conditions
§ §360eee. Definitions§360eee. Definitions
§ §360ff. Priority review to encourage tre§360ff. Priority review to encourage treatments for rare pediatric diseases
§ §360fff. Definitions§360fff. Definitions
§ §360hh. Definitions§360hh. Definitions
§ §360ii. Program of control§360ii. Program of control
§ §360jj. Studies by Secretary§360jj. Studies by Secretary
§ §360kk. Performance standards for electr§360kk. Performance standards for electronic products
§ §360ll. Notification of defects in and r§360ll. Notification of defects in and repair or replacement of electronic products
§ §360mm. Imports§360mm. Imports
§ §360nn. Inspection, records, and reports§360nn. Inspection, records, and reports
§ §360oo. Prohibited acts§360oo. Prohibited acts
§ §360pp. Enforcement§360pp. Enforcement
§ §360rr. Federal-State cooperation§360rr. Federal-State cooperation
§ §360ss. State standards§360ss. State standards
§ 353a–1Enhanced communication
§ 355c–1Report
§ 355–1Risk evaluation and mitigation strategies
§ 355–2Actions for delays of generic drugs and biosimilar biological products
§ 356c–1Annual reporting on drug shortages
§ 356–1Accelerated approval of priority countermeasures
§ 356–2Accelerated approval Council
§ §360bbb–0. Expanded access policy requir§360bbb–0. Expanded access policy required for investigational drugs
§ §360bbb–0a. Investigational drugs for us§360bbb–0a. Investigational drugs for use by eligible patients
§ 360a–1Clinical trials
§ 360b–1Priority zoonotic animal drugs
§ 360c–1Reporting
§ 360e–1Pediatric uses of devices
§ 360g–1Agency documentation and review of significant decisions regarding devices
§ 360h–1Program to improve the device recall system
§ 360n–1Priority review for qualified infectious disease products
§ §360bbb–1. Dispute resolution§360bbb–1. Dispute resolution
§ §360ccc–1. Index of legally marketed una§360ccc–1. Index of legally marketed unapproved new animal drugs for minor species
§ §360ddd–1. Regulation of medical gases§360ddd–1. Regulation of medical gases
§ §360eee–1. Requirements§360eee–1. Requirements
§ §360ee–1. FDA rare neurodegenerative dis§360ee–1. FDA rare neurodegenerative disease grant program
§ §360fff–1. Submission of requests§360fff–1. Submission of requests
§ §360ff–1. Targeted drugs for rare diseas§360ff–1. Targeted drugs for rare diseases
§ 360a–2Susceptibility test interpretive criteria for microorganisms
§ 360g–2Third party data transparency
§ 360n–2Ensuring cybersecurity of devices
§ §360bbb–2. Classification of products§360bbb–2. Classification of products
§ §360ccc–2. Designated new animal drugs f§360ccc–2. Designated new animal drugs for minor use or minor species
§ §360ddd–2. Inapplicability of drug fees §360ddd–2. Inapplicability of drug fees to designated medical gases
§ §360eee–2. National standards for prescr§360eee–2. National standards for prescription drug wholesale distributors
§ §360fff–2. Eligibility determinations; d§360fff–2. Eligibility determinations; data submission; filing
§ 360e–3Breakthrough devices
§ §360bbb–3. Authorization for medical pro§360bbb–3. Authorization for medical products for use in emergencies
§ §360bbb–3a. Emergency use of medical pro§360bbb–3a. Emergency use of medical products
§ §360bbb–3b. Products held for emergency §360bbb–3b. Products held for emergency use
§ §360bbb–3c. Expedited development and re§360bbb–3c. Expedited development and review of medical products for emergency uses
§ §360eee–3. National standards for third-§360eee–3. National standards for third-party logistics providers
§ §360fff–3. GRASE determination§360fff–3. GRASE determination
§ 360e–4Predetermined change control plans for devices
§ §360bbb–4. Countermeasure development, r§360bbb–4. Countermeasure development, review, and technical assistance
§ §360bbb–4a. Priority review to encourage§360bbb–4a. Priority review to encourage treatments for agents that present national security threats
§ §360bbb–4b. Medical countermeasure maste§360bbb–4b. Medical countermeasure master files
§ §360eee–4. Uniform national policy§360eee–4. Uniform national policy
§ §360fff–4. Guidance; other provisions§360fff–4. Guidance; other provisions
§ §360bbb–5. Critical Path Public-Private §360bbb–5. Critical Path Public-Private Partnerships
§ §360bbb–5a. Emerging technology program§360bbb–5a. Emerging technology program
§ §360bbb–6. Risk communication§360bbb–6. Risk communication
§ §360fff–6. Non-sunscreen time and extent§360fff–6. Non-sunscreen time and extent applications
§ §360bbb–7. Notification§360bbb–7. Notification
§ §360fff–7. Report§360fff–7. Report
§ §360bbb–8. Consultation with external ex§360bbb–8. Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments
§ §360bbb–8a. Optimizing global clinical t§360bbb–8a. Optimizing global clinical trials
§ §360bbb–8b. Use of clinical investigatio§360bbb–8b. Use of clinical investigation data from outside the United States
§ §360bbb–8c. Patient participation in med§360bbb–8c. Patient participation in medical product discussion
§ §360bbb–8d. Notification, nondistributio§360bbb–8d. Notification, nondistribution, and recall of controlled substances
§ §360fff–8. Sunset§360fff–8. Sunset
Chapter SUBCHAPTER VI—COSMETICS
§ 361Adulterated cosmetics
§ 362Misbranded cosmetics
§ 363Regulations making exemptions
§ 364Definitions
§ 364aAdverse events
§ 364bGood manufacturing practice
§ 364cRegistration and product listing
§ 364dSafety substantiation
§ 364eLabeling
§ 364fRecords
§ 364gMandatory recall authority
§ 364hSmall businesses
§ 364iExemption for certain products and facilities
§ 364jPreemption
Chapter SUBCHAPTER VII—GENERAL AUTHORITY
§ 371Regulations and hearings
§ 372Examinations and investigations
§ 373Records
§ 374Inspection
§ 374aInspections relating to food allergens
§ 375Publicity
§ 376Examination of sea food on request of packer; marking food with results; fees; penalties
§ 377Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
§ 378Advertising of foods
§ 379Confidential information
§ 379aPresumption of existence of jurisdiction
§ 379bConsolidated administrative and laboratory facility
§ 379dAutomation of Food and Drug Administration
§ 379eListing and certification of color additives for foods, drugs, devices, and cosmetics
§ 379fRecovery and retention of fees for freedom of information requests
§ 379gDefinitions
§ 379hAuthority to assess and use drug fees
§ 379iDefinitions
§ 379jAuthority to assess and use device fees
§ 379kInformation system
§ 379lEducation
§ 379oEnvironmental impact
§ 379rNational uniformity for nonprescription drugs
§ 379sPreemption for labeling or packaging of cosmetics
§ 379vSafety report disclaimers
§ §379aa. Serious adverse event reporting §379aa. Serious adverse event reporting for nonprescription drugs
§ §379dd. Establishment and functions of t§379dd. Establishment and functions of the Foundation
§ 379d–1Conflicts of interest
§ 379h–1Fees relating to advisory review of prescription-drug television advertising
§ 379j–1Reauthorization; reporting requirements
§ 379k–1Electronic format for submissions
§ §379aa–1. Serious adverse event reportin§379aa–1. Serious adverse event reporting for dietary supplements
§ §379dd–1. Location of Foundation§379dd–1. Location of Foundation
§ 379d–2Policy on the review and clearance of scientific articles published by FDA employees
§ 379h–2Reauthorization; reporting requirements
§ §379dd–2. Activities of the Food and Dru§379dd–2. Activities of the Food and Drug Administration
§ 379d–3Streamlined hiring authority
§ 379d–3aHiring authority for scientific, technical, and professional personnel
§ 379d–3bStrategic Workforce Plan and report
§ 379d–4Reporting requirements
§ 379d–5Guidance document regarding product promotion using the Internet
§ 379j–11Definitions
§ 379j–12Authority to assess and use animal drug fees
§ 379j–13Reauthorization; reporting requirements
§ 379j–21Authority to assess and use generic new animal drug fees
§ 379j–22Reauthorization; reporting requirements
§ 379j–31Authority to collect and use fees
§ 379j–41Definitions
§ 379j–42Authority to assess and use human generic drug fees
§ 379j–43Reauthorization; reporting requirements
§ 379j–51Definitions
§ 379j–52Authority to assess and use biosimilar biological product fees
§ 379j–53Reauthorization; reporting requirements
§ 379j–61Definitions
§ 379j–62Authority to assess and use outsourcing facility fees
§ 379j–71Definitions
§ 379j–72Authority to assess and use OTC monograph fees
§ 379j–73Reauthorization; reporting requirements
Chapter SUBCHAPTER VIII—IMPORTS AND EXPORTS
§ 381Imports and exports
§ 382Exports of certain unapproved products
§ 383Office of International Relations
§ 384Importation of prescription drugs
§ 384aForeign supplier verification program
§ 384bVoluntary qualified importer program
§ 384cInspection of foreign food facilities
§ 384dAccreditation of third-party auditors
§ 384eRecognition of foreign government inspections
§ 384fStrengthening FDA and CBP coordination and capacity
§ 384gRestricting entrance of illicit drugs
Chapter SUBCHAPTER IX—TOBACCO PRODUCTS
§ 387Definitions
§ 387aFDA authority over tobacco products
§ 387bAdulterated tobacco products
§ 387cMisbranded tobacco products
§ 387dSubmission of health information to the Secretary
§ 387eAnnual registration
§ 387fGeneral provisions respecting control of tobacco products
§ 387gTobacco product standards
§ 387hNotification and other remedies
§ 387iRecords and reports on tobacco products
§ 387jApplication for review of certain tobacco products
§ 387kModified risk tobacco products
§ 387lJudicial review
§ 387mEqual treatment of retail outlets
§ 387nJurisdiction of and coordination with the Federal Trade Commission
§ 387oRegulation requirement
§ 387pPreservation of State and local authority
§ 387qTobacco Products Scientific Advisory Committee
§ 387rDrug products used to treat tobacco dependence
§ 387sUser fees
§ 387tLabeling, recordkeeping, records inspection
§ 387uStudies of progress and effectiveness
§ 387vReporting on tobacco regulation activities
§ 387a–1Final rule
§ 387f–1Enforcement action plan for advertising and promotion restrictions
Chapter SUBCHAPTER X—MISCELLANEOUS
§ 391Separability clause
§ 392Exemption of meats and meat food products
§ 393Food and Drug Administration
§ 393aOffice of Pediatric Therapeutics
§ 394Scientific review groups
§ 395Loan repayment program
§ 396Practice of medicine
§ 397Contracts for expert review
§ 398Notices to States regarding imported food
§ 399Grants to enhance food safety
§ 399aOffice of the Chief Scientist
§ 399bOffice of Women's Health
§ 399cImproving the training of State, local, territorial, and tribal food safety officials
§ 399dEmployee protections
§ 399eNanotechnology
§ 399fEnsuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
§ 399gFood and Drug Administration Intercenter Institutes
§ 399hNational Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
§ 399iFood and Drug Administration Working Capital Fund
Chapter 10POULTRY AND POULTRY PRODUCTS INSPECTION
§ 451Congressional statement of findings
§ 452Congressional declaration of policy
§ 453Definitions
§ 454Federal and State cooperation in development and administration of State poultry product inspection programs
§ 455Inspection in official establishments
§ 456Operation of premises, facilities and equipment
§ 457Labeling and container standards
§ 458Prohibited acts
§ 459Compliance by all establishments
§ 460Miscellaneous activities subject to regulation
§ 461Offenses and punishment
§ 462Reporting of violations; notice; opportunity to present views
§ 463Rules and regulations
§ 464Exemptions
§ 465Limitations upon entry of poultry products and other materials into official establishments
§ 466Imports
§ 467Inspection services
§ 467aAdministrative detention; duration; pending judicial proceedings; notification of government authorities; release; removal of official marks
§ 467bSeizure and condemnation
§ 467cFederal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations; United States as plaintiff; subpenas
§ 467dAdministration and enforcement; applicability of penalty provisions; conduct of inquiries; power and jurisdiction of courts
§ 467eNon-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
§ 467fFederal Food, Drug, and Cosmetic Act applications
§ 468Cost of inspection; overtime
§ 469Authorization of appropriations
§ 471Safe Meat and Poultry Inspection Panel
§ 472Interstate shipment of poultry inspected by Federal and State agencies for certain small establishments
§ 473Grants for improvements to meat and poultry facilities to allow for interstate shipment
Chapter SUBCHAPTER I—INSPECTION REQUIREMENTS; ADULTERATION AND MISBRANDING
§ 601Definitions
§ 602Congressional statement of findings
§ 603Examination of animals prior to slaughter; use of humane methods
§ 604Post mortem examination of carcasses and marking or labeling; destruction of carcasses condemned; reinspection
§ 605Examination of carcasses brought into slaughtering or packing establishments, and of meat food products issued from and returned thereto; conditions for entry
§ 606Inspection and labeling of meat food products
§ 607Labeling, marking, and container requirements
§ 608Sanitary inspection and regulation of slaughtering and packing establishments; rejection of adulterated meat or meat food products
§ 609Examination of animals and food products thereof, slaughtered and prepared during nighttime
§ 610Prohibited acts
§ 611Devices, marks, labels, and certificates; simulations
§ 612Notification
§ 613Plans and reassessments
§ 615Inspection of carcasses, meat of which is intended for export
§ 616Inspectors of carcasses, etc., meat of which is intended for export; certificates of condition
§ 617Clearance prohibited to vessel carrying meat for export without inspector's certificate
§ 618Delivery of inspectors' certificates, and of copies
§ 619Marking, labeling, or other identification to show kinds of animals from which derived; separate establishments for preparation and slaughtering activities
§ 620Imports
§ 621Inspectors to make examinations provided for; appointment; duties; regulations
§ 622Bribery of or gifts to inspectors or other officers and acceptance of gifts
§ 623Exemptions from inspection requirements
§ 624Storage and handling regulations; violations; exemption of establishments subject to non-Federal jurisdiction
§ 625Inapplicability of certain requirements to catfish
§ 626Purchase of tags, labels, stamps, and certificates
Chapter SUBCHAPTER II—MEAT PROCESSORS AND RELATED INDUSTRIES
§ 641Prohibition of subchapter I inspection of articles not intended for use as human food; denaturation or other identification prior to distribution in commerce; inedible articles
§ 642Recordkeeping requirements
§ 643Registration of business, name of person, and trade names
§ 644Regulation of transactions, transportation, or importation of 4–D animals to prevent use as human food
§ 645Federal provisions applicable to State or Territorial business transactions of a local nature and not subject to local authority
Chapter SUBCHAPTER III—FEDERAL AND STATE COOPERATION
§ 661Federal and State cooperation
Chapter SUBCHAPTER IV—AUXILIARY PROVISIONS
§ 671Inspection services; refusal or withdrawal; hearing; business unfitness based upon certain convictions; other provisions for withdrawal of services unaffected; responsible connection with business; finality of Secretary's actions; judicial review; record
§ 672Administrative detention; duration; pending judicial proceedings; notification of governmental authorities; release
§ 673Seizure and condemnation
§ 674Federal court jurisdiction of enforcement and injunction proceedings and other kinds of cases; limitations of section 607(e) of this title
§ 675Assaulting, resisting, or impeding certain persons; murder; protection of such persons
§ 676Violations
§ 677Other Federal laws applicable for administration and enforcement of chapter; location of inquiries; jurisdiction of Federal courts
§ 678Non-Federal jurisdiction of federally regulated matters; prohibition of additional or different requirements for establishments with inspection services and as to marking, labeling, packaging, and ingredients; recordkeeping and related requirements; concurrent jurisdiction over distribution for human food purposes of adulterated or misbranded and imported articles; other matters
§ 679Application of Federal Food, Drug, and Cosmetic Act
§ 679aSafe Meat and Poultry Inspection Panel
§ 679bPasteurization of meat and poultry
§ 679cExpansion of Food Safety Inspection Service activities
§ 680Authorization of appropriations
Chapter SUBCHAPTER IV–A—INSPECTIONS BY FEDERAL AND STATE AGENCIES
§ 683Interstate shipment of meat inspected by Federal and State agencies for certain small establishments
Chapter SUBCHAPTER V—MISCELLANEOUS PROVISIONS
§ 692Inspection extended to reindeer
§ 693Inspection of dairy products for export
§ 694Authorization of appropriations
§ 695Payment of cost of meat-inspection service; exception
Chapter SUBCHAPTER I—CONTROL AND ENFORCEMENT
§ 801Congressional findings and declarations: controlled substances
§ 801aCongressional findings and declarations: psychotropic substances
§ 802Definitions
§ 811Authority and criteria for classification of substances
§ 812Schedules of controlled substances
§ 813Treatment of controlled substance analogues
§ 814Removal of exemption of certain drugs
§ 821Rules and regulations
§ 822Persons required to register
§ 822aPrescription drug take back expansion
§ 823Registration requirements
§ 824Denial, revocation, or suspension of registration
§ 825Labeling and packaging
§ 826Production quotas for controlled substances
§ 826aAttorney General report on drug shortages
§ 827Records and reports of registrants
§ 828Order forms
§ 829Prescriptions
§ 829aDelivery of a controlled substance by a pharmacy to an administering practitioner
§ 830Regulation of listed chemicals and certain machines
§ 831Additional requirements relating to online pharmacies and telemedicine
§ 832Suspicious orders
§ 841Prohibited acts A
§ 842Prohibited acts B
§ 843Prohibited acts C
§ 844Penalties for simple possession
§ 844aCivil penalty for possession of small amounts of certain controlled substances
§ 846Attempt and conspiracy
§ 847Additional penalties
§ 848Continuing criminal enterprise
§ 849Transportation safety offenses
§ 850Information for sentencing
§ 851Proceedings to establish prior convictions
§ 852Application of treaties and other international agreements
§ 853Criminal forfeitures
§ 854Investment of illicit drug profits
§ 855Alternative fine
§ 856Maintaining drug-involved premises
§ 858Endangering human life while illegally manufacturing controlled substance
§ 859Distribution to persons under age twenty-one
§ 860Distribution or manufacturing in or near schools and colleges
§ 860aConsecutive sentence for manufacturing or distributing, or possessing with intent to manufacture or distribute, methamphetamine on premises where children are present or reside
§ 861Employment or use of persons under 18 years of age in drug operations
§ 862Denial of Federal benefits to drug traffickers and possessors
§ 862aDenial of assistance and benefits for certain drug-related convictions
§ 862bSanctioning for testing positive for controlled substances
§ 863Drug paraphernalia
§ 864Anhydrous ammonia
§ 864aGrants to reduce production of methamphetamines from anhydrous ammonia
§ 865Smuggling methamphetamine or methamphetamine precursor chemicals into the United States while using facilitated entry programs
§ 871Attorney General
§ 871aSemiannual reports to Congress
§ 872Education and research programs of Attorney General
§ 872aPublic-private education program
§ 873Cooperative arrangements
§ 874Advisory committees
§ 875Administrative hearings
§ 876Subpenas
§ 877Judicial review
§ 878Powers of enforcement personnel
§ 879Search warrants
§ 880Administrative inspections and warrants
§ 881Forfeitures
§ 882Injunctions
§ 883Enforcement proceedings
§ 884Immunity and privilege
§ 885Burden of proof; liabilities
§ 886Payments and advances
§ 886aDiversion Control Fee Account
§ 887Coordination and consolidation of post-seizure administration
§ 889Production control of controlled substances
§ 890Review of Federal sales of chemicals usable to manufacture controlled substances
§ 901Severability
§ 902Savings provisions
§ 903Application of State law
§ 904Payment of tort claims
Chapter SUBCHAPTER II—IMPORT AND EXPORT
§ 951Definitions
§ 952Importation of controlled substances
§ 953Exportation of controlled substances
§ 954Transshipment and in-transit shipment of controlled substances
§ 955Possession on board vessels, etc., arriving in or departing from United States
§ 956Exemption authority
§ 957Persons required to register
§ 958Registration requirements
§ 959Possession, manufacture, or distribution of controlled substance
§ 960Prohibited acts A
§ 960aForeign terrorist organizations, terrorist persons and groups
§ 961Prohibited acts B
§ 962Second or subsequent offenses
§ 963Attempt and conspiracy
§ 964Additional penalties
§ 965Applicability of part E of subchapter I
§ 966Authority of Secretary of the Treasury
§ 967Smuggling of controlled substances; investigations; oaths; subpenas; witnesses; evidence; production of records; territorial limits; fees and mileage of witnesses
§ 968Service of subpena; proof of service
§ 969Contempt proceedings
§ 970Criminal forfeitures
§ 971Notification, suspension of shipment, and penalties with respect to importation and exportation of listed chemicals
Chapter 15EGG PRODUCTS INSPECTION
§ 1031Congressional statement of findings
§ 1032Congressional declaration of policy
§ 1033Definitions
§ 1034Inspection of egg products
§ 1035Sanitary operating practices in official plants
§ 1036Pasteurization and labeling of egg products at official plants
§ 1037Prohibited acts
§ 1038Cooperation with appropriate State and other governmental agencies; utilization of employees; reimbursement
§ 1039Eggs and egg products not intended for use as human food; inspection; denaturing or otherwise identifying
§ 1040Recordkeeping requirements; persons required to maintain records; scope of disclosure; access to records
§ 1041Enforcement provisions
§ 1042Reporting of violation to United States attorney for institution of criminal proceedings; procedure; presentation of views
§ 1043Rules and regulations; administration and enforcement
§ 1044Exemption of certain activities
§ 1045Limitation on entry of eggs and egg products and other materials into official plants
§ 1046Imports
§ 1047Refusal or withdrawal of inspection services; hearing; grounds; person deemed to have responsible connection with business; finality of order of Secretary; judicial review; other provisions for refusal of services unaffected
§ 1048Administrative detention of violative articles; duration; release; removal of official marks
§ 1049Seizure and condemnation proceedings
§ 1050Jurisdiction of district courts; United States as plaintiff in enforcement and restraining proceedings; subpenas for witnesses
§ 1051Other Federal laws applicable for administration and enforcement of chapter; prosecution of inquiries; exercise of jurisdiction
§ 1052State or local regulation
§ 1053Inspection and administration costs
§ 1054Annual report to Congressional committees
§ 1055Authorization of appropriations
§ 1056Separability
Chapter SUBCHAPTER I—GENERAL PROVISIONS
§ 1101Congressional findings
§ 1102Congressional declaration of national policy
Chapter SUBCHAPTER II—DRUG ABUSE POLICY COORDINATION
§ 1115Notice relating to the control of dangerous drugs
Chapter SUBCHAPTER IV—OTHER FEDERAL PROGRAMS
§ 1171Drug abuse prevention function appropriations
§ 1177Special project grants and contracts
§ 1178Records and audit
§ 1179National Drug Abuse Training Center
§ 1181Contract authority
Chapter 19PESTICIDE MONITORING IMPROVEMENTS
§ 1401Pesticide monitoring and enforcement information
§ 1402Foreign pesticide information
§ 1403Pesticide analytical methods
Chapter SUBCHAPTER I—OFFICE OF NATIONAL DRUG CONTROL POLICY
§ 1505aAnnual report on development and deployment of narcotics detection technologies
Chapter SUBCHAPTER II—DRUG-FREE COMMUNITIES
§ 1521Findings
§ 1522Purposes
§ 1523Definitions
§ 1524Authorization of appropriations
§ 1531Establishment of drug-free communities support program
§ 1532Program authorization
§ 1533Information collection and dissemination with respect to grant recipients
§ 1534Technical assistance and training
§ 1535Supplemental grants for coalition mentoring activities
§ 1536Community-based coalition enhancement grants to address local drug crises
Chapter 21BIOMATERIALS ACCESS ASSURANCE
§ 1601Findings
§ 1602Definitions
§ 1603General requirements; applicability; preemption
§ 1604Liability of biomaterials suppliers
§ 1605Procedures for dismissal of civil actions against biomaterials suppliers
§ 1606Subsequent impleader of dismissed biomaterials supplier
Chapter 22NATIONAL DRUG CONTROL POLICY
§ 1701Definitions
§ 1702Office of National Drug Control Policy
§ 1703Appointment and duties of Director and Deputy Directors
§ 1704Coordination with National Drug Control Program agencies in demand reduction, supply reduction, and State and local affairs
§ 1705Development, submission, implementation, and assessment of National Drug Control Strategy
§ 1706High Intensity Drug Trafficking Areas Program
§ 1708Emerging Threats Committee, plan, and media campaign
§ 1710Drug Interdiction Coordinator and Committee
§ 1710aRequirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
§ 1711Authorization of appropriations
§ 1713Authorization of use of environmentally-approved herbicides to eliminate illicit narcotics crops
§ 1714Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions
§ 1715GAO audit
Chapter 24INTERNATIONAL NARCOTICS TRAFFICKING
§ 1901Findings and policy
§ 1902Purpose
§ 1903Public identification of significant foreign narcotics traffickers and required reports
§ 1904Blocking assets and prohibiting transactions
§ 1905Authorities
§ 1906Enforcement
§ 1907Definitions
§ 1908Judicial Review Commission on Foreign Asset Control
Chapter SUBCHAPTER I—ANTI-DOPING AGENCY
§ 2001Designation of United States Anti-Doping Agency
§ 2002Records, audit, and report
§ 2003Authorization of appropriations
§ 2004Information sharing
Chapter SUBCHAPTER II—NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE
§ 2011Definitions
§ 2012Establishment of clearinghouse and advisory council
§ 2013NMIC requirements and review
§ 2014Authorization of appropriations
Chapter 26FOOD SAFETY
§ 2101Findings
§ 2102Ensuring the safety of pet food
§ 2103Ensuring efficient and effective communications during a recall
§ 2104State and Federal cooperation
§ 2105Enhanced aquaculture and seafood inspection
§ 2106Consultation regarding genetically engineered seafood products
§ 2107Sense of Congress
§ 2108Annual report to Congress
§ 2109Publication of annual reports
§ 2110Rule of construction
Chapter SUBCHAPTER I—IMPROVING CAPACITY TO PREVENT FOOD SAFETY PROBLEMS
§ 2201Performance standards
§ 2202National Agriculture and Food Defense Strategy
§ 2203Food and Agriculture Coordinating Councils
§ 2204Building domestic capacity
§ 2205Food allergy and anaphylaxis management
§ 2206Alcohol-related facilities
Chapter SUBCHAPTER II—IMPROVING CAPACITY TO DETECT AND RESPOND TO FOOD SAFETY PROBLEMS
§ 2221Food emergency response network
§ 2222Integrated consortium of laboratory networks
§ 2223Enhancing tracking and tracing of food and recordkeeping
§ 2224Surveillance
§ 2225Decontamination and disposal standards and plans
Chapter SUBCHAPTER III—IMPROVING THE SAFETY OF IMPORTED FOOD
§ 2241Inspection by the Secretary of Commerce
§ 2242Foreign offices of the Food and Drug Administration
§ 2243Smuggled food
Chapter SUBCHAPTER IV—MISCELLANEOUS PROVISIONS
§ 2251Jurisdiction; authorities
§ 2252Compliance with international agreements
Chapter 28SANCTIONS WITH RESPECT TO FOREIGN TRAFFICKERS OF ILLICIT SYNTHETIC OPIOIDS
§ 2301Sense of Congress
§ 2302Definitions
Chapter SUBCHAPTER I—SANCTIONS WITH RESPECT TO FOREIGN OPIOID TRAFFICKERS
§ 2311Identification of foreign opioid traffickers
§ 2312Imposition of sanctions
§ 2313Description of sanctions
§ 2313aDesignation of transactions of sanctioned persons as of primary money laundering concern
§ 2314Waivers
§ 2315Procedures for judicial review of classified information
§ 2316Briefings on implementation
Chapter SUBCHAPTER II—OTHER MATTERS
§ 2331Director of National Intelligence program on use of intelligence resources in efforts to sanction foreign opioid traffickers
§ 2332Authorization of appropriations
§ 2333Regulatory authority
§ 2334Termination
§ 2335Exception relating to importation of goods
Chapter 28AFENTANYL ERADICATION AND NARCOTICS DETERRENCE OFF FENTANYL
§ 2341Definitions
Chapter SUBCHAPTER I—SANCTIONS IN RESPONSE TO NATIONAL EMERGENCY RELATING TO FENTANYL TRAFFICKING
§ 2351Finding; policy
§ 2352Use of national emergency authorities; reporting
§ 2353Imposition of sanctions with respect to fentanyl trafficking by transnational criminal organizations
§ 2354Penalties; waivers; exceptions
§ 2355Treatment of forfeited property of transnational criminal organizations
Chapter SUBCHAPTER II—ANTI-MONEY LAUNDERING MATTERS
§ 2361Treatment of transnational criminal organizations in suspicious transactions reports of the Financial Crimes Enforcement Network
Chapter SUBCHAPTER III—EXCEPTION RELATING TO IMPORTATION OF GOODS
§ 2371Exception relating to importation of goods
Chapter 29INTERNATIONAL SPORTS DOPING
§ 2401Definitions
§ 2402Major international doping fraud conspiracies
§ 2403Criminal penalties and statute of limitations
§ 2404Coordination and sharing of information with USADA